These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3917598)

  • 1. Incomplete and delayed bioavailability of sublingual nitroglycerin.
    Noonan PK; Benet LZ
    Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets.
    Kwon HR; Green P; Curry SH
    Biopharm Drug Dispos; 1992 Mar; 13(2):141-52. PubMed ID: 1550909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.
    Jensen KM; Mikkelsen S
    Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutical evaluation of methylcellulose as an excipient for nitroglycerin tablets.
    Shibuya F; Kuramoto K; Koizumi H; Uehara N; Nakagawa F; Tamura Z; Murayama M; Kawakubo K; Kawahara T; Ohshiro M
    J Pharmacobiodyn; 1985 May; 8(5):352-6. PubMed ID: 3930694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of two spray formulations of nitroglycerin.
    Sanders SW; Michaelis K; Maurette JM; Jaeger H
    J Pharm Sci; 1986 Mar; 75(3):244-6. PubMed ID: 3084758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
    Jensen KM; Dahl JB
    Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.
    Noonan PK; Benet LZ
    Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioavailability of oral nitroglycerin.
    Noonan PK; Benet LZ
    J Pharm Sci; 1986 Mar; 75(3):241-3. PubMed ID: 3084757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of time course of plasma nitroglycerin levels to echocardiographic, arterial pressure and heart rate changes after sublingual administration of nitroglycerin.
    Wei JY; Reid PR
    Am J Cardiol; 1981 Oct; 48(4):778-82. PubMed ID: 6792895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of a new transdermal nitroglycerin delivery system.
    Noonan PK; Gonzalez MA; Ruggirello D; Tomlinson J; Babcock-Atkinson E; Ray M; Golub A; Cohen A
    J Pharm Sci; 1986 Jul; 75(7):688-91. PubMed ID: 3093667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma nitroglycerin levels after sublingual, oral and topical administration.
    Blumenthal HP; Fung HL; McNiff EF; Yap SK
    Br J Clin Pharmacol; 1977 Apr; 4(2):241-2. PubMed ID: 405030
    [No Abstract]   [Full Text] [Related]  

  • 14. New transdermal and transmucosal nitroglycerin delivery systems in patients with ischaemic heart disease.
    Metelitsa VI; Martsevich SYu ; Piotrovskii VK; Ryabokon OS; Blagodatskikh SV
    Eur J Clin Pharmacol; 1987; 32(1):5-10. PubMed ID: 3108009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
    Marmor A
    Am J Cardiol; 1990 Jun; 65(21):43J-45J. PubMed ID: 2112337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood levels after sublingual nitroglycerin.
    Armstrong PW; Armstrong JA; Marks GS
    Circulation; 1979 Mar; 59(3):585-8. PubMed ID: 104803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
    Straehl P; Galeazzi RL
    Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations and hemodynamic effects of intravenous, sublingual, and aerosolized nitroglycerin in patients undergoing cardiac catheterization.
    Curry SH; Lopez LM; Lambert CR; Kwon HR; Stack RK
    Biopharm Drug Dispos; 1993 Mar; 14(2):107-18. PubMed ID: 8453021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam.
    Greenblatt DJ; Divoll M; Harmatz JS; Shader RI
    J Pharm Sci; 1982 Feb; 71(2):248-52. PubMed ID: 6121043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.